Document is current

Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers

Crossref DOI link: https://doi.org/10.1186/S40880-017-0208-5

Published: 2017-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY